Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avance eZZe is a functional sleep-aid beverage developed by Best World International. It is formulated using liposomal technology, which is intended to improve the absorption and efficacy of its active ingredients compared to standard formulations. The product is designed to enhance sleep quality and alleviate stress-related sleep disturbances. Clinical research, such as trial NCT07172607, evaluates its impact on sleep architecture and the autonomic nervous system in individuals with sleep disorders and anxiety-depression symptoms. The formulation typically includes neuroactive compounds such as gamma-aminobutyric acid (GABA) and L-theanine, which promote relaxation and support healthy sleep cycles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Avance eZZe.